MOL Hungarian Oil & Gas PLC (0RUK)
London Exchange · UK · prices in GBP · close of 20 Oct 2026
Key indicators
| Last close | GBP 2,922.00 |
|---|---|
| 52-week range | 2,920.09 – 5,196.25 |
| Return, 1 month / 3 months | +0.0% / +0.1% |
| Return, 1 year / 3 years | +0.1% / +0.2% |
| Trend | Uptrend |
| RSI (14) | 100 |
| Volatility (1 year) | 0.1% |
| Worst drawdown (1 year) | 0.0% |
| Average daily value traded | 8.97M GBP |
| Dividend yield | 0.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
MOL Hungarian Oil and Gas PLC is an integrated energy company based in Budapest, Hungary. It explores for and produces crude oil and natural gas, refines crude into fuels and other petroleum products, and runs a network of retail filling stations under the MOL brand in Hungary and neighbouring countries. The company also makes petrochemicals and supplies fuels and lubricants to motorists, businesses and industrial customers across Central and Eastern Europe.
MOL Hungarian Oil & Gas PLC trades under the code 0RUK on the London Exchange in UK, with its price quoted in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
MOL Hungarian Oil & Gas PLC (0RUK) trades on the London Exchange in UK. It last closed at GBP 2,922.00 on 20 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 967 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.1% and over the last three months it rose 0.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.1% | ||
| From 52-week high | 0.0% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 0.1% | ||
| 6-month return | 0.1% | ||
| 12-month return, skipping the last month | 0.1% | ||
| Stability (higher is calmer) | 99 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 0.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | 0.0% | ||
| Liquidity | 51 · Fair | Moderate trading activity. | |
| Average daily value traded | 8.97M GBP | ||
| Zero-volume days | 90.0% | ||
| Income | 34 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.1% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.0% |
| 3 months | +0.1% |
| 6 months | +0.1% |
| 1 year | +0.1% |
| 3 years | +0.2% |
| 5 years | +0.3% |
Signals
| 50-day / 200-day average | 2,921.09 / 2,920.34 |
|---|---|
| Golden / death cross (60 days) | Golden, 25 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 669.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Sep 2026 | GBX 1.9055 |
| 4 Jun 2025 | GBX 1.1000 |
| 24 May 2024 | GBX 1.5000 |
| 20 Jul 2023 | GBX 2.0243 |
| 20 Jul 2022 | GBX 1.0000 |
| 10 Aug 2021 | GBX 0.9502 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.